Sample Detail | Central BioHub GmbH: Order Human Biospecimens Online

Product Page

CBH Donor ID CBH Sample ID Matrix Quantity (Unit) Age Gender Price Cart
CBHD7624335 CBHS7624372 Serum 0.40 (mL) 82 Female 16

Samples will be shipped within 5 to 10 business days.

General Data
CBH Donor ID
CBH Master ID
CBH Sample ID
Matrix Type
Matrix
Storage Container
Temperature
Storage Temperature
Freeze Thaw Cycles
Sample Condition

CBHD7624335
CBHM7624335
CBHS7624356
Serum
Serum
Cryotube (0.5 ml)
-18 °C
-18 °C
0
perfect
Quantity Information
Quantity
Unit
Total Quantity

0.40
mL
2.2
Donor
Age
Gender

82
Female
Laboratory
Lab Parameter
Result Measured In
Result Obtained From
Result Raw
Result Numerical
Result Unit
Result Interpretation
Result Date
Cut Off Raw
Cut Off Numerical
Cut Off Unit
Cut Off Remarks
Test Method
Test Kit
Test Kit Manufacturer
Test System
Test System Manufacturer

Procalcitonin (PCT)
serum
this donation
0.76
0.76
ng/mL
Positive
29.07.2021
< 0.10
0.10
ng/ml
sepsis unlikely: 0.10 - < 0.50. sepsis possible: >= 0.50 - < 2.00. sepsis likely: >= 2.00 - < 10.00. severe sepsis/septic shock most likely: >= 10.00
ECLIA (Electro Chemiluminescence Immuno Assay)
Elecsys BRAHMS Procalcitonin (PCT)
Thermo Fisher Scientific (Brahms)/Roche
Cobas 8000 (e801)
Roche
Clinical Diagnosis
Diagnosis
ICD Code
ICD Code Version
ICD Code Translation
Diagnosis Date

Acute respiratory failure, unspecified whether with hypoxia or hypercapniaBenign essential hypertension Without mention of hypertensive urgencyCarrier of other specified bacterial diseasesChronic kidney disease, stage 3 (moderate)COVID-19, virus identifiedElsewhere classified, hospital-acquired pneumonia that occurs 48 hours or more after admissionFaecal incontinenceGlomerular disorders in diabetes mellitusHypokalemiaIsolationNeed for assistance due to reduced mobilityNeed for assistance with personal careOther specified hypothyroidismOther viral pneumoniaParoxysmal atrial fibrillationPleural effusion, not elsewhere classifiedSpecial screening examination for infectious and parasitic diseasesStaphylococcal infection, unspecified siteSystemic Inflammatory Response Syndrome of infectious origin without organ failureType 2 diabetes mellitus with diabetic nephropathyUnspecified protein-energy malnutrition
J96.00I10.00Z22.3N18.3U07.1U69.01R15N08.3E87.6Z29.0Z74.0Z74.1E03.8J12.8I48.0J90Z11A49.0R65.0E11.21E46
ICD-10-GMICD-10-GMICD-10-GMICD-10-GMICD-10-GMICD-10-GMICD-10-GMICD-10-GMICD-10-GMICD-10-GMICD-10-GMICD-10-GMICD-10-GMICD-10-GMICD-10-GMICD-10-GMICD-10-GMICD-10-GMICD-10-GMICD-10-GMICD-10-GM
Acute respiratory failure, unspecified whether with hypoxia or hypercapniaBenign essential hypertension Without mention of hypertensive urgencyCarrier of other specified bacterial diseasesChronic kidney disease, stage 3 (moderate)COVID-19, virus identifiedElsewhere classified, hospital-acquired pneumonia that occurs 48 hours or more after admissionFaecal incontinenceGlomerular disorders in diabetes mellitusHypokalemiaIsolationNeed for assistance due to reduced mobilityNeed for assistance with personal careOther specified hypothyroidismOther viral pneumoniaParoxysmal atrial fibrillationPleural effusion, not elsewhere classifiedSpecial screening examination for infectious and parasitic diseasesStaphylococcal infection, unspecified siteSystemic Inflammatory Response Syndrome of infectious origin without organ failureType 2 diabetes mellitus with diabetic nephropathyUnspecified protein-energy malnutrition
informationinformationinformationinformationinformationinformationinformationinformationinformationinformationinformationinformationinformationinformationinformationinformationinformationinformationinformationinformationinformation
Preanalytics
Country of Collection
Date of Collection

Germany
17.12.2020
Ethics
Procurement Type
Informed Consent

Left over
not required
Specific Products
Product Count

1